King v. Burwell Decision: Lost Sales, Uncertainty At Stake For Biopharma
This article was originally published in The Pink Sheet Daily
Executive Summary
The pending Supreme Court ruling in a case challenging distribution of government subsidies for insurance provided under the Affordable Care Act could lead to billions in lost pharmaceutical sales and significant uncertainty in the insurance market.